MIRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MIRA Pharmaceuticals Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, there are no significant trading trends, and the stock lacks clear positive catalysts or strong financial data to support a buy decision. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on this investment is advisable.
The MACD is below 0 and negatively contracting, indicating bearish momentum. The RSI is neutral at 41.228, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.98, with resistance at 1.021 and support at 0.938.
MIRA Pharmaceuticals has submitted a Phase 2a clinical trial protocol to the FDA for Ketamir-2, which could be a future catalyst if the trial progresses successfully.
The stock has a 50% chance of declining by 4.22% in the next week, and there is no significant trading activity from hedge funds or insiders. Additionally, the technical indicators suggest bearish momentum.
No financial data available for assessment.
No analyst ratings or price target changes available.
